Prescription of chondroitin sulfate in back pains
One of the promising areas of pharmacotherapy in degenerative-dystrophic lesions of the joints, such as osteoarthritis (OA), is the use of chondroprotectors (CP). CPs belong to the group of Symptomatic Slow Acting Drugs for OsteoArthritis (SYSADOA). Among CPs, chondroitin sulfate (CS) is considered...
Main Authors: | O. A. Shavlovskaya, I. D. Romanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-01-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5478 |
Similar Items
-
Experience with the use of chondroitin sulfate for pain in the back
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01) -
The use of chondroitin sulfate (Mucosat) for the treatment of chronic back pain and osteoarthritis
by: O. A. Shavlovskaya, et al.
Published: (2020-03-01) -
Antiresorptive activity of pharmacological chondroitin sulfate in the older age group
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01) -
A new look at back pain treatment in light of the latest ESCEO guidelines
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01) -
Pharmacoeconomic analysis of various adjunctive pharmacotherapy strategies for back pain using comparative method
by: P. A. Balunov
Published: (2018-04-01)